Back to results
US 12,679,832 B2Granted
Compounds and their uses as CD38 inhibitors
AssigneeNanjing Immunophage Biotech Co., Ltd.
InventorsJianbei Xi, Guohuang Fan, Jianfei Wang, Kin Chiu Fong
Life of this patent
Estimating the term…
Abstract
The present invention provides compounds of Formula I which can be used as CD38 inhibitors; methods for the production of the compounds of the invention; pharmaceutical compositions comprising the compounds of the invention; as well as uses and methods for treating a disease mediated by CD38 by administering the compounds of the invention.
Claims28
A compound of formula I:
- or a pharmaceutically acceptable salt thereof, wherein:
- A1 is
- wherein A1 is optionally substituted with 0, 1 or 2 substituents independently selected from methyl and trifluoromethyl;
- A2 is
- wherein A2 is optionally substituted with 0 or 1 substituent selected from —CN, methyl, isopropyl, trifluoromethyl, methoxy, cyclobutoxy, oxetan-3-yloxy, —NH2, —NHCH3, and —N(CH3)2;
- A3 is
- wherein A3 is optionally substituted with 0, 1 or 2 substituents independently selected from —CN, —OCH2CH2OCH3, —COCH3, —F, —Cl, methyl, trifluoromethyl, hydroxyethoxy, carboxymethoxy, hydroxy, and methoxy;
- and
- R is H or C1-6 alkyl.
6 more elements
Dependencies are inferred from the claim text.